Portfolio company
Genome Compiler
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides a software platform for genetic engineering and synthetic biology, allowing scientists to design, manage and order DNA sequences.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Synthace
This company develops a cloud-based software platform that automates biological experiments and data analysis for pharmaceutical, agriscience and industrial biotechnology research teams.
Asimov
This company develops a synthetic biology platform integrating software and genetic engineering to help biotechnology firms design and manufacture therapeutics and viral vectors.
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
Molecular Assemblies
This company develops enzymatic DNA synthesis technology to provide long, high-quality oligonucleotides for researchers in synthetic biology, therapeutics, diagnostics and data storage.
Constructive Bio
This company engineers synthetic genomes and programmable cells to produce novel proteins and biomaterials for pharmaceutical, agricultural and manufacturing partners.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
Twist Bioscience
This company manufactures synthetic DNA on silicon chips for customers in the drug discovery, diagnostics, agriculture, and academic research sectors.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
